Synthesis and Pharmacological Characterization of 2-(2,6-Dichlorophenyl)-1((1S,3R)-5-(3-hydroxy-3-methylbutyl)-3-(hydroxymethyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl)ethan-1-one (LY3154207), a Potent, Subtype Selective, and Orally Available Positive Allosteric Modulator of the Human Dopamine D1 Receptor

被引:42
作者
Hao, Junliang [1 ]
Beck, James P. [1 ]
Schaus, John M. [1 ]
Krushinski, Joseph H. [1 ]
Chen, Qi [1 ]
Beadle, Christopher D. [1 ]
Vidal, Paloma [1 ]
Reinhard, Matthew R. [1 ]
Dressman, Bruce A. [1 ]
Massey, Steven M. [1 ]
Boulet, Serge L. [1 ]
Cohen, Michael P. [1 ]
Watson, Brian M. [1 ]
Tupper, David [1 ]
Gardiner, Kevin M. [1 ]
Myers, Jason [1 ]
Johansson, Anette M. [1 ]
Richardson, Jeffery [1 ]
Richards, Daniel S. [6 ]
Hembre, Erik J. [1 ]
Remick, David M. [2 ]
Coates, David A. [2 ]
Bhardwaj, Rajni M. [2 ]
Diseroad, Benjamin A. [2 ]
Bender, David [2 ]
Stephenson, Greg [2 ]
Wolfangel, Craig D. [2 ]
Diaz, Nuria [2 ]
Getman, Brian G. [3 ]
Wang, Xu-shan [3 ]
Heinz, Beverly A. [3 ]
Cramer, Jeff W. [4 ]
Zhou, Xin [4 ]
Maren, Deanna L. [5 ]
Falcone, Julie F. [5 ]
Wright, Rebecca A. [5 ]
Mitchell, Stephen N. [5 ]
Carter, Guy [5 ]
Yang, Charles R. [5 ]
Bruns, Robert F. [1 ]
Svensson, Kjell A. [5 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, Lilly Res Labs, Small Mol Drug Dev, Indianapolis, IN 46285 USA
[3] Eli Lilly & Co, Lilly Res Labs, Quantitat Biol, Indianapolis, IN 46285 USA
[4] Eli Lilly & Co, Lilly Res Labs, Drug Disposit, Indianapolis, IN 46285 USA
[5] Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery, Indianapolis, IN 46285 USA
[6] AMRI UK Ltd, Sunninghill Rd, Windlesham GU20 6PH, Surrey, England
关键词
PROTEIN-COUPLED RECEPTORS; D-1; RECEPTOR; PHARMACEUTICAL COCRYSTALS; ACETYLCHOLINE-RELEASE; AGONIST DIHYDREXIDINE; COGNITIVE DEFICITS; IN-VITRO; EXPRESSION; DISCOVERY; LIGANDS;
D O I
10.1021/acs.jmedchem.9b01234
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Clinical development of catechol-based orthosteric agonists of the dopamine D1 receptor has thus far been unsuccessful due to multiple challenges. To address these issues, we identified LY3154207 (3) as a novel, potent, and subtype selective human D1 positive allosteric modulator (PAM) with minimal allosteric agonist activity. Conformational studies showed LY3154207 adopts an unusual boat conformation, and a binding pose with the human D1 receptor was proposed based on this observation. In contrast to orthosteric agonists, LY3154207 showed a distinct pharmacological profile without a bell-shaped dose-response relationship or tachyphylaxis in preclinical models. Identification of a crystalline form of free LY3154207 from the discovery lots was not successful. Instead, a novel cocrystal form with superior solubility was discovered and determined to be suitable for development. This cocrystal form was advanced to clinical development as a potential first-in-class D1 PAM and is now in phase 2 studies for Lewy body dementia.
引用
收藏
页码:8711 / 8732
页数:22
相关论文
共 107 条
[1]   Enantioselective deprotonation of 4-tert-butylcyclohexanone by conformationally constrained chiral lithium amide bases [J].
Aggarwal, VK ;
Humphries, PS ;
Fenwick, A .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1999, (20) :2883-2889
[2]  
[Anonymous], 2015, SCHROD REL 2015 3
[3]  
[Anonymous], 2008, SCHROD MAESTR VERS 8
[4]  
[Anonymous], 2017, STUD LY3154207 PART
[5]  
[Anonymous], 2015, MOL OP ENV MOE
[6]  
[Anonymous], 2012, TOPAS ACAD V5
[7]   Methylphenidate improves prefrontal cortical cognitive function through α2 adrenoceptor and dopamine D1 receptor actions: Relevance to therapeutic effects in Attention Deficit Hyperactivity Disorder [J].
Arnsten, Amy F. T. ;
Dudley, Anne G. .
BEHAVIORAL AND BRAIN FUNCTIONS, 2005, 1 (1)
[8]   Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia [J].
Arnsten, Amy F. T. ;
Girgis, Ragy R. ;
Gray, David L. ;
Mailman, Richard B. .
BIOLOGICAL PSYCHIATRY, 2017, 81 (01) :67-77
[9]   The Neurobiology of Thought: The Groundbreaking Discoveries of Patricia Goldman-Rakic 1937-2003 [J].
Arnsten, Amy F. T. .
CEREBRAL CORTEX, 2013, 23 (10) :2269-2281
[10]  
Ates A, 2017, WO Patent, Patent No. [2017178377A1, 2017178377]